medigraphic.com

2009, Number 1

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2009; 47 (1)

Chemotaxis and Disease

Rojas-Dotor S, Pérez-Ramos J, Rico-Rosillo MG

Language: Spanish
References: 40
Page: 51-56
PDF size: 40.92 Kb.


ABSTRACT

Chemotaxis is defined as the ability of living cells to determine the direction of locomotion through a concentration gradient of attractant and repellent substances. Biological substances such as complement and its components, as well as their relationship with the disease are described.


REFERENCES

  1. Abbas AK, Lichtman AH. Cellular and molecular immunology. Fifth edition. Philadelphia: Saunders Elsevier; 2004. p. 243-274.

  2. Wilkinson PC. Chemotaxis and inflammation. London, UK: Churchill Livingstone; 1982. p. 1-34.

  3. Chollet-Martin S, Gougerot-Pocidalo MA. Hereditary polymorphonuclear neutrophil deficiencies. Transfus Clin Biol 2000;7(6):533-539.

  4. Roitt IM. Immunology. Fifth edition. London, UK: Mosby; 1998. p. 61-69.

  5. Schiffman E. Leukocyte chemotaxis. Annu Rev Physiol 1982;44:553-568.

  6. Snyderman R, Goetzl EJ. Molecular and cellular mechanisms of leukocyte chemotaxis. Science 1981;213(4510):830-837.

  7. Kobayashi K. Adhesion molecules and leukocyte functions. Rinsho Byori 1995;43(7):665-668.

  8. Prieschl EE, Kulmburg PA, Baumruker T. The nomenclature of chemokines. Int Arch Allergy Immunol 1995;107(4):475-483.

  9. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182(4):1169- 1174.

  10. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 1983;220(4597):568-575.

  11. La Rosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, Taylor L, et al. Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 1992;267(35):25402-25406.

  12. Leonard EJ, Skeel A, Yoshimura T, Rankin J. Secretion of monocyte chemoattractant protein-1 (MCP-1) by human mononuclear phagocytes. Adv Exp Med Biol 1993;351:55-64.

  13. Gerish G. Chemotaxis in Dictyostellium. Ann Rev Physiol 1982;44:535-552.

  14. Bullard DC. Adhesion molecules in inflammatory diseases: insights from knockout mice. Immunol Res 2002;26(1-3):27-33.

  15. Johnston A, Gudjonsson J, Sigmunsdottir H, Ludviksson B, Valdimarsson H. The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules. Clin Immunol 2005;114(2):154-163.

  16. Yonekawa K, Harlan J. Targeting leukocyte integrins in human diseases. J Leukoc Biol 2005;77(2):129-140.

  17. Bunting M, Harris ES, McIntyre TM, Prescott SM, Zimmerman GA. Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol 2002;9(1):30-35.

  18. Ward DM, Shiflett SL, Kaplan J. Chediak-Higashi syndrome: a clinical and molecular view of a rare lysosomal storage disorder. Curr Mol Med 2002;(5)2:469-477.

  19. Boocock Gr, Morrison JA, Popovic M, Richards N, Ellio L, Durrie PR, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003;33(1):97-101.

  20. Gerard C, Hugli TE. Identification of classical anaphylatoxin as the C5a molecule: evidence of a modulator role for the olysaccharide united in human des-arg 74 C5a. Proc Natl Acad Sci 1981; 78(3):1833-1837.

  21. Marder SR, Chenoweth DE, Goldstein IM, Pérez HD. Chemotactic response of human peripheral blood monocyte to the complement-derived C5ades- Arg. J Immunol 1985;134(5):3325-3331.

  22. Kolakowski LF Jr, Lu B, Gerard C, Gerard NP. Probing the “message: address” sites for chemoattractant binding to the C5a receptor. Mutagenesis of hydrophilic and proline residues within the transmembrane segments. J Biol Chem 1995;270 (30):18077-18082.

  23. FaIk W, Leonard EJ. Human monocyte chemotaxis: migrating cells are a subpopulation with multiple chemotaxin specificities on each cell. Infect Immunol 1980;29(3):953-959.

  24. Daffern PJ, Pfeifer PH, Ember JA, HugIi TE. C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation. J Exp Med 1995 181(6):2119-2127.

  25. Mrowietz U, Jurgens G. A method for the determination of leukocyte migration for large sample numbers by automated densitometry quantification. J Biochem Biophys Methods 1995;30(1):49-58.

  26. Altman L, Snyderman R, Oppenheim J, Mergenhagen S. A human mononuclear leukocyte chemotatic factor. Characterization specificity and kinetics of production by homologous leukocytes. J Immunol 1973;110(3):801-810.

  27. Cyster JG. Chemokines and cell migration in secondary lymphoid organs. Science 1999;286(5447): 2098-2102.

  28. Nikel R, Beck LA, Stellato C, Schleimer R. Chemokines and allergic disease. J Allergy Clin Immunol 1999;104(4 Pt 1):723-742.

  29. Kraver T, Vilcek J, Oppenheim JJ. Proinflammatory cytokines. En: Paul WE, editor. Fundamental immunology. Fourth edition. Philadelphia: Lippincott Raven; 1999. p. 775-811.

  30. Ip W, Wong CK, Wang CB, Tian YP, Lam CW. Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor induce adhesion and chemotaxis of human eosinophils via p38 mitogenactivated protein kinase and nuclear factor kappa. Immunopharmacol Immunotoxicol 2005;27(3): 371-393.

  31. Randolph D, Huang G, Carruthers C, Bromley L, Chaplin D. The role of CCR7 in Th1 and TH2 cell localization and delivery of B cell help in vivo. Science 1999;286(5447):2159-2162.

  32. Loetscher P, Ugoccioni M, Bordoli L, Baggiolini M, Moser B, Chizzolini C, et al. CCR5 is characteristic of Th1 lymphocytes. Nature 1998;391(6665):344-345.

  33. Zingoni A, Soto H, Hedrick JA, Stoppacciaro A, Storlarzzi CT, Sinigaglia F, et al. The chemokine receptor CCR8 is preferentially expressed in Th2 but not Th1 cells. J Immunol 1998;161(2):547-551.

  34. Ying S, Humbert M, Barkans J, Corrigan CJ, Pfister R, Menz G, et al. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997;158(7):3539-3544.

  35. Lai CK, Ho SS, Chan CH, Leung R, Lai KN. Gene expression of interleukin-3 and granulocyte macrophage colony-stimulating factor in circulating CD4+ T cells in acute severe asthma. Clin Exp Allergy 1996;26(2):138-146.

  36. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996;17(3):138-146.

  37. Luster AD. Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338(7):436-445.

  38. Berin MC, Eckmann L, Broide DH, Kagnoff MF. Regulated production of the helper 2-type T cell chemoattractant TARC by human bronchial epithelial cells in vitro and in human lung xenografts. Am J Respir Cell Mol Biol 2001;24(4):382-389.

  39. Lazcano MD, Negrete GMC, Montes VAR, Valencia ME, García-Sancho FC, Franco MF, et al. La quimiocina regulada activada del timo (TARC) se libera en las vías aéreas de pacientes asmáticos. Rev Inst Nal Enf Resp Mex 2002;15(4):201-205.

  40. Cano Londoño NF, Montoya-Guarin CJ. Las quimioquinas: citocinas proinflamatorias y reguladoras del tráfico celular. Iatreia 2001;14(1):57-72.




2020     |     www.medigraphic.com